Search results
What Is Psoriatic Arthritis? 3 MDs Weigh In
PopSugar· 6 days agoPsoriasis affects about three percent of American adults, but the disorder can raise the risk of having more than skin scales and plaques. About 30 percent of people with ...
Psoriasis pain: Prevalence and how to manage it
Medical News Today· 6 days agoPeople may describe psoriasis pain as itchy, achy, or stinging, with the feeling varying from person to person. Strategies such as using distraction,...
Amjevita and dosage: Strengths, forms, how to inject, and more
Medical News Today· 4 days agoAmjevita comes as a solution subcutaneous injection. Your doctor will determine the best dosage to...
MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Average Recommendation of “Moderate Buy” from...
ETF DAILY NEWS· 4 hours agoShares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) have earned an average recommendation of “Moderate Buy” from the twelve research firms that are presently covering the firm ...
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Medscape· 5 days agoUnlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 5 days agoTreatment with guselkumab also offered statistically significant and clinically meaningful...
Amgen (NASDAQ:AMGN) Price Target Cut to $328.00
ETF DAILY NEWS· 2 days agoAmgen (NASDAQ:AMGN – Get Free Report) had its price target reduced by Royal Bank of Canada from $332.00 to $328.00 in a note issued to investors on Friday, Benzinga reports. The brokerage presently ...
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks via Yahoo Finance· 4 days agoKymera (KYMR) reports a narrower-than-expected loss in the first quarter. The company expects the...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 4 days agoTremfya is presently approved to treat certain patients with plaque psoriasis and active psoriatic ...
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First...
Morningstar· 7 days agoU.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab) Alvotech will manufacture ...